224 related articles for article (PubMed ID: 21542925)
61. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1.
Ferrari A; Bisogno G; Macaluso A; Casanova M; D'Angelo P; Pierani P; Zanetti I; Alaggio R; Cecchetto G; Carli M
Cancer; 2007 Apr; 109(7):1406-12. PubMed ID: 17330850
[TBL] [Abstract][Full Text] [Related]
62. [Mortality in nuclear workers of the French electricity company: period 1968-2003].
Rogel A; Joly K; Metz-Flamant C; Laurent O; Tirmarche M; Hubert D; Garcier Y; Laurier D
Rev Epidemiol Sante Publique; 2009 Aug; 57(4):257-65. PubMed ID: 19540685
[TBL] [Abstract][Full Text] [Related]
63. Neurofibromatosis 1-associated neuropathies: a reappraisal.
Drouet A; Wolkenstein P; Lefaucheur JP; Pinson S; Combemale P; Gherardi RK; Brugières P; Salama J; Ehre P; Decq P; Créange A
Brain; 2004 Sep; 127(Pt 9):1993-2009. PubMed ID: 15289270
[TBL] [Abstract][Full Text] [Related]
64. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
65. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
66. Intestinal tumors in neurofibromatosis 1 with special reference to fatal gastrointestinal stromal tumors (GIST).
Ylä-Outinen H; Loponen N; Kallionpää RA; Peltonen S; Peltonen J
Mol Genet Genomic Med; 2019 Sep; 7(9):e927. PubMed ID: 31397088
[TBL] [Abstract][Full Text] [Related]
67. Updated mortality study of workers at a petroleum refinery in Torrance, California, 1959 to 1997.
Wong O; Harris F; Rosamilia K; Raabe GK
J Occup Environ Med; 2001 Dec; 43(12):1089-102. PubMed ID: 11765680
[TBL] [Abstract][Full Text] [Related]
68. A malignant peripheral nerve sheath tumor of the mediastinum in a patient with neurofibromatosis type 1: report of a case.
Kawachi R; Takei H; Furuyashiki G; Koshi-Ishi Y; Goya T
Surg Today; 2008; 38(10):945-7. PubMed ID: 18820872
[TBL] [Abstract][Full Text] [Related]
69. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
70. Long-term causes of death among pediatric patients with cancer.
Horn SR; Stoltzfus KC; Mackley HB; Lehrer EJ; Zhou S; Dandekar SC; Fox EJ; Rizk EB; Trifiletti DM; Rao PM; Zaorsky NG
Cancer; 2020 Jul; 126(13):3102-3113. PubMed ID: 32298481
[TBL] [Abstract][Full Text] [Related]
71. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma).
Jacobsen S; Halberg P; Ullman S
Br J Rheumatol; 1998 Jul; 37(7):750-5. PubMed ID: 9714351
[TBL] [Abstract][Full Text] [Related]
72. NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.
Kluwe L; Friedrich RE; Korf B; Fahsold R; Mautner VF
Hum Mutat; 2002 Mar; 19(3):309. PubMed ID: 11857752
[TBL] [Abstract][Full Text] [Related]
73. Mortality in female and male French Olympians: a 1948-2013 cohort study.
Antero-Jacquemin J; Rey G; Marc A; Dor F; Haïda A; Marck A; Berthelot G; Calmat A; Latouche A; Toussaint JF
Am J Sports Med; 2015 Jun; 43(6):1505-12. PubMed ID: 25813868
[TBL] [Abstract][Full Text] [Related]
74. Mortality in the Sami population of North Norway, 1970-98.
Tynes T; Haldorsen T
Scand J Public Health; 2007; 35(3):306-12. PubMed ID: 17530553
[TBL] [Abstract][Full Text] [Related]
75. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort.
Lhatoo SD; Johnson AL; Goodridge DM; MacDonald BK; Sander JW; Shorvon SD
Ann Neurol; 2001 Mar; 49(3):336-44. PubMed ID: 11261508
[TBL] [Abstract][Full Text] [Related]
76. Epidemiology of neurofibromatosis type 1.
Friedman JM
Am J Med Genet; 1999 Mar; 89(1):1-6. PubMed ID: 10469430
[TBL] [Abstract][Full Text] [Related]
77. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
78. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
79. Subsequent mortality experience in five-year survivors of childhood, adolescent and young adult cancer in Scotland: a population based, retrospective cohort study.
Brewster DH; Clark D; Hopkins L; Bauer J; Wild SH; Edgar AB; Hamish Wallace W
Eur J Cancer; 2013 Oct; 49(15):3274-83. PubMed ID: 23756361
[TBL] [Abstract][Full Text] [Related]
80. A mortality study among workers in a French aluminium reduction plant.
Moulin JJ; Clavel T; Buclez B; Laffitte-Rigaud G
Int Arch Occup Environ Health; 2000 Jul; 73(5):323-30. PubMed ID: 10963416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
